Implantable pump could ease diabetes management for 40 patients
NCT ID NCT06739811
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 4 times
Summary
This study is testing a new implantable insulin pump (MIIPS 2020) in 40 adults with type 1 diabetes whose blood sugar is hard to control with standard insulin shots or external pumps. The pump is placed inside the body and delivers insulin directly, aiming to reduce dangerous high and low blood sugar episodes. The main goal is to see how accurately the pump delivers insulin over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE I DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21100, France
-
CHU Lille - Hôpital Huriez
NOT_YET_RECRUITINGLille, France, 59037, France
-
CHU de Nancy - Hôpital d'Adultes de Brabois
NOT_YET_RECRUITINGNancy, France, 54511, France
-
CHU de Toulouse - Hôpital Rangueil
RECRUITINGToulouse, France, 31059, France
-
Centre Hospitalier Sud Francilien
NOT_YET_RECRUITINGCorbeil-Essonnes, France, 91100, France
-
Centre Hospitalier Universitaire De Montpellier
RECRUITINGMontpellier, France, 34295, France
-
Hôpital Européen Marseille
RECRUITINGMarseille, 13003, France
-
Hôpital Lariboisière & Fernand-Widal
RECRUITINGParis, France
-
Hôpital Saint André -Centre Hospitalier Universitaire de Bordeaux
NOT_YET_RECRUITINGBordeaux, France, 33000, France
-
Hôpitaux Universitaires de Strasbourg - Nouvel Hôpital Civil
RECRUITINGStrasbourg, France
-
Isala Zwolle
RECRUITINGZwolle, Netherlands, 8025 AB, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.